title: Reconsideration of age as a contraindication for curative therapy of sickle cell disease.
authors: Program in Occupational Therapy, Division of Pediatric Hematology-Oncology, Department of Pediatrics, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri.
authors: Allison A
authors: AA
authors: King
authors: Division of Oncology, Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri.
authors: John F
authors: JF
authors: DiPersio
mesh_terms: D000074323:Alemtuzumab; D000755:Anemia, Sickle Cell / Q000628:therapy*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D020123:Sirolimus / Q000008:administration & dosage*; D017086:beta-Thalassemia / Q000628:therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D000074323:Alemtuzumab; D020123:Sirolimus